Brokerages Set Aemetis, Inc. (NASDAQ:AMTX) Price Target at $12.95

Aemetis, Inc. (NASDAQ:AMTX) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $12.95.

A number of research firms have recently commented on AMTX. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com raised Aemetis to a “sell” rating in a research note on Monday, January 27th.

Institutional Trading of Aemetis

Institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC grew its position in Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares in the last quarter. State Street Corp boosted its stake in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares during the last quarter. Susquehanna Fundamental Investments LLC grew its holdings in shares of Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after acquiring an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Aemetis by 29.6% in the fourth quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock valued at $247,000 after acquiring an additional 20,961 shares during the last quarter. Finally, Wellington Management Group LLP bought a new stake in Aemetis during the third quarter worth about $177,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Stock Performance

Shares of NASDAQ:AMTX opened at $2.16 on Friday. The company has a 50 day moving average price of $2.85 and a two-hundred day moving average price of $2.86. The company has a market capitalization of $107.44 million, a PE ratio of -0.96 and a beta of 1.44. Aemetis has a 52 week low of $2.04 and a 52 week high of $7.03.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the prior year, the company earned ($0.59) EPS. On average, sell-side analysts forecast that Aemetis will post -2.07 earnings per share for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.